Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Randomised clinical trial of long term glutathione supplementation offers protection from oxidative damage, improves HbA1c in elderly type 2 diabetic patients

View ORCID ProfileSaurabh Kalamkar, Jhankar Acharya, Arjun Kolappurath Madathil, Vijay Gajjar, View ORCID ProfileUma Divate, Sucheta Karandikar-Iyer, View ORCID ProfilePranay Goel, View ORCID ProfileSaroj Ghaskadbi
doi: https://doi.org/10.1101/2021.04.27.21256157
Saurabh Kalamkar
1Department of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune- 411007, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Saurabh Kalamkar
Jhankar Acharya
1Department of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune- 411007, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arjun Kolappurath Madathil
2Biology Division, Indian Institute of Science Education and Research, Pune- 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vijay Gajjar
3Jehangir Hospital, Pune- 411001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uma Divate
4Jehangir Clinical Development Centre, Jehangir Hospital, Pune- 411001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Uma Divate
Sucheta Karandikar-Iyer
5Iyer Clinic, Pune- 411030, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pranay Goel
2Biology Division, Indian Institute of Science Education and Research, Pune- 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pranay Goel
  • For correspondence: ssg@unipune.ac.in pgoel@iiserpune.ac.in
Saroj Ghaskadbi
1Department of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune- 411007, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Saroj Ghaskadbi
  • For correspondence: ssg@unipune.ac.in pgoel@iiserpune.ac.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Sustained hyperglycemia in type 2 diabetes is associated with low levels of the endogenous antioxidant glutathione (GSH), which leads to oxidative stress and tissue damage. It is therefore important to investigate whether oral GSH supplementation would restore GSH levels, and also help improve redox state and glycaemia in diabetic individuals. We conducted a pragmatic clinical trial to assess effectiveness of oral GSH supplementation along with anti-diabetic treatment. 104 non-diabetic and 250 diabetic individuals were recruited. All the 250 diabetic individuals were on anti-diabetic therapy; of these 125 were given oral GSH supplementation additionally for a period of six months. Fasting and PP glucose and insulin, HbA1c, GSH and the oxidative DNA damage marker 8-OHdG were measured at the recruitment time and after three and six months of supplementation. GSH supplementation increased blood GSH and decreased 8-OHdG significantly within three months in diabetic individuals. It also reduced HbA1c within three months and stabilized it thereafter in diabetic population overall. Patients above 55 years benefited more as evidenced by a significant decrease in HbA1c and 8-OHdG and an increase in fasting insulin. Data suggest that GSH supplementation can be used as an adjunct therapy to anti-diabetic treatment to achieve better glycemic targets, especially in elderly population.

Trial registered This study has been registered with Clinical Trials Registry-India (CTRI/2018/01/011257)

Novelty bullets

  • Oral GSH supplementation replenishes body stores of GSH and significantly reduces oxidative DNA damage in diabetic patients over six months.

  • HbA1c is lowered at three months and is stabilized thereafter.

  • A significant decrease in HbA1c and elevated fasting insulin was observed in people older than 55 years.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

CTRI/2018/01/011257 (Clinical Trials Registry-India)

Funding Statement

This work was financially supported by XIIth Plan-Innovation Grant (University Grants Commission (UGC), Savitribai Phule Pune University, Pune. We also acknowledge partial financial support from UGC-Centre for Advanced Studies (CAS) and Department of Science and Technology-Promotion of University Research and Scientific Excellence (PURSE) program of the Department of Zoology, Savitribai Phule Pune University. SK is a recipient of a Junior Research fellowship from the Council of Scientific and Industrial Research (CSIR), India. AK is financially supported by DST Inspire, Government of India.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Ethical Committee of Jehangir Hospital Development Center, Pune (Dr. Ravindra Ghooi, Chairman, Ethics committee Jehangir clinical development center ECN- ECR/352/Inst/NIH/2013); Institutional Biosafety Committee of SPPU (Bot/27A/15), Pune; and Institutional Ethical Committee of IISER, Pune. Signed informed consent was obtained from all the subjects at the time of enrollment in the study after explaining the purpose and nature of the study. All participants in this study were de-identified using a numbered code. This study is registered with Clinical Trials Registry-India (CTRI/2018/01/011257).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† These authors share first author position.

Data Availability

All datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Randomised clinical trial of long term glutathione supplementation offers protection from oxidative damage, improves HbA1c in elderly type 2 diabetic patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Randomised clinical trial of long term glutathione supplementation offers protection from oxidative damage, improves HbA1c in elderly type 2 diabetic patients
Saurabh Kalamkar, Jhankar Acharya, Arjun Kolappurath Madathil, Vijay Gajjar, Uma Divate, Sucheta Karandikar-Iyer, Pranay Goel, Saroj Ghaskadbi
medRxiv 2021.04.27.21256157; doi: https://doi.org/10.1101/2021.04.27.21256157
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Randomised clinical trial of long term glutathione supplementation offers protection from oxidative damage, improves HbA1c in elderly type 2 diabetic patients
Saurabh Kalamkar, Jhankar Acharya, Arjun Kolappurath Madathil, Vijay Gajjar, Uma Divate, Sucheta Karandikar-Iyer, Pranay Goel, Saroj Ghaskadbi
medRxiv 2021.04.27.21256157; doi: https://doi.org/10.1101/2021.04.27.21256157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (419)
  • Anesthesia (97)
  • Cardiovascular Medicine (894)
  • Dentistry and Oral Medicine (166)
  • Dermatology (101)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
  • Epidemiology (8745)
  • Forensic Medicine (4)
  • Gastroenterology (403)
  • Genetic and Genomic Medicine (1845)
  • Geriatric Medicine (175)
  • Health Economics (386)
  • Health Informatics (1282)
  • Health Policy (642)
  • Health Systems and Quality Improvement (489)
  • Hematology (206)
  • HIV/AIDS (387)
  • Infectious Diseases (except HIV/AIDS) (10521)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (216)
  • Neurology (1744)
  • Nursing (100)
  • Nutrition (264)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (457)
  • Oncology (959)
  • Ophthalmology (279)
  • Orthopedics (107)
  • Otolaryngology (174)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (262)
  • Pediatrics (553)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1836)
  • Public and Global Health (3963)
  • Radiology and Imaging (649)
  • Rehabilitation Medicine and Physical Therapy (340)
  • Respiratory Medicine (532)
  • Rheumatology (214)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (165)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (105)
  • Urology (78)